US 12,168,673 B2
Prodrugs derived from nicotinic acid and ribose
G. Mani Subramanian, Los Altos Hills, CA (US); Gangadhara Ganapati, Palo Alto, CA (US); Manoj Chandrasinhji Desai, Martinez, CA (US); Nikhil Saji Zachariah, Bangalore (IN); Ajay Kumar K S, Bangalore (IN); and Gautham Tumkur Pranesh, Bangalore (IN)
Assigned to Mitopower, Inc., Palo Alto, CA (US)
Filed by Mitopower, Inc., Palo Alto, CA (US)
Filed on Mar. 2, 2023, as Appl. No. 18/177,444.
Claims priority of provisional application 63/315,640, filed on Mar. 2, 2022.
Prior Publication US 2023/0279035 A1, Sep. 7, 2023
Int. Cl. C07H 13/02 (2006.01); A61P 13/12 (2006.01); C07H 11/04 (2006.01)
CPC C07H 13/02 (2013.01) [A61P 13/12 (2018.01); C07H 11/04 (2013.01)] 24 Claims
 
1. A compound having the structure:

OG Complex Work Unit Chemistry
or pharmaceutically acceptable salts, hydrates or solvates thereof.